Phase II multicenter study of talazoparib for somatic BRCA1/2 mutant metastatic breast cancer. N Vidula, E Blouch, NK Horick, E Basile, S Damodaran,MC Liu,AN ShahJOURNAL OF CLINICAL ONCOLOGY（2021）引用 2|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
